Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Klinik Nielsen, Århus ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 7.5%   Bankruptcy risk   17.0% 13.7% 8.3% 7.0% 5.2% 5.5% 18.3% 14.7%   Credit score (0-100)   11 17 31 34 41 41 7 14   Credit rating   BB BB BB BBB BBB BBB B BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -118 -85.7 45.6 165 306 148 0.0 0.0   EBITDA   -118 -85.7 45.6 165 306 115 0.0 0.0   EBIT   -122 -88.7 42.1 157 299 110 0.0 0.0   Pre-tax profit (PTP)   -122.2 -88.8 42.0 156.4 297.5 107.8 0.0 0.0   Net earnings   -122.2 -88.8 42.0 158.1 231.9 82.3 0.0 0.0   Pre-tax profit without non-rec. items   -122 -88.8 42.0 156 297 108 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   11.0 8.0 30.7 22.5 15.2 10.0 0.0 0.0   Shareholders equity total   -72.2 -161 -119 39.2 271 353 303 303   Interest-bearing liabilities   99.5 191 251 142 0.0 0.0 0.0 0.0   Balance sheet total (assets)   70.9 80.2 158 254 391 491 303 303   Net Debt   98.1 181 207 12.5 -224 -304 -303 -303     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -118 -85.7 45.6 165 306 148 0.0 0.0   Gross profit growth   0.0% 27.5% 0.0% 262.5% 85.6% -51.8% -100.0% 0.0%   Employees   0 1 1 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   71 80 158 254 391 491 303 303   Balance sheet change%   0.0% 13.1% 96.9% 61.0% 53.7% 25.6% -38.2% 0.0%   Added value   -122.2 -88.7 42.1 156.9 299.2 110.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   7 -6 19 -16 -15 -10 -10 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   103.3% 103.5% 92.5% 95.0% 97.6% 74.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -85.4% -46.2% 16.3% 59.1% 92.8% 25.0% 0.0% 0.0%   ROI %   -122.8% -61.0% 19.1% 72.7% 131.4% 35.0% 0.0% 0.0%   ROE %   -172.3% -117.5% 35.3% 160.5% 149.5% 26.4% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   -50.5% -66.8% -43.0% 15.4% 69.4% 72.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -82.9% -210.6% 453.9% 7.6% -73.2% -263.6% 0.0% 0.0%   Gearing %   -137.8% -118.9% -210.6% 362.3% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.1% 0.0% 0.3% 2.5% 0.0% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   0.2 0.1 0.2 0.7 2.1 2.3 0.0 0.0   Current Ratio   0.3 0.2 0.4 1.0 3.1 3.5 0.0 0.0   Cash and cash equivalent   1.4 11.0 43.8 129.3 224.5 304.1 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -97.7 -183.4 -164.1 2.2 244.7 331.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 -89 42 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -86 46 0 0 0 0 0   EBIT / employee   0 -89 42 0 0 0 0 0   Net earnings / employee   0 -89 42 0 0 0 0 0